Short Description
Trimetazidine 35mg Tablets are an antianginal medicine used as an additional treatment for stable angina pectoris, a condition that causes chest discomfort when the heart muscle receives insufficient oxygen. They work by improving how heart muscle cells use energy during periods of reduced oxygen supply, helping manage angina symptoms alongside other treatments.
What Is Trimetazidine 35mg?
Trimetazidine 35mg is an oral antianginal medicine containing 35mg of trimetazidine, commonly supplied as a modified-release tablet. It belongs to a group of medicines known as metabolic antianginal agents.
Unlike medicines that primarily reduce heart rate or blood pressure, trimetazidine acts on energy metabolism within heart muscle cells.
It may be prescribed as an additional treatment for adults with stable angina when first-line antianginal medicines do not adequately control symptoms or are not tolerated. Approved uses may differ between countries.
Uses
Trimetazidine 35mg may be prescribed to:
Provide additional symptomatic treatment for stable angina pectoris in adults.
Help reduce the frequency of angina episodes when used alongside appropriate first-line antianginal treatment.
Improve tolerance to physical activity limited by stable angina symptoms in selected patients.
Trimetazidine is not intended to relieve an acute angina attack or treat a heart attack.
The appropriate treatment and dose should be determined by a healthcare professional based on symptoms, kidney function, existing heart medicines, and local prescribing recommendations.
How Does Trimetazidine Work?
Trimetazidine works by influencing how heart muscle cells produce energy. It partially inhibits an enzyme involved in fatty acid metabolism, known as long-chain 3-ketoacyl-CoA thiolase.
This encourages heart muscle cells to use glucose more efficiently for energy production when oxygen availability is reduced.
By helping preserve cellular energy during periods of reduced blood supply, trimetazidine may improve symptoms of stable angina. Benefits are generally assessed over several weeks of treatment, and the response varies between patients.
How to Take Trimetazidine
Take Trimetazidine exactly as prescribed by your healthcare professional.
Trimetazidine 35mg modified-release tablets are generally taken twice daily, with the morning and evening meals.
Take doses at approximately the same times each day.
Swallow modified-release tablets whole with water.
Do not crush or chew the tablets, as this may interfere with their modified-release properties.
Continue taking other prescribed heart medicines unless your healthcare professional advises otherwise.
Do not change the dose or stop treatment without professional advice.
If you miss a dose, take the next dose at its usual scheduled time. Do not take a double dose to make up for a missed dose.
Important Safety Information
Before taking Trimetazidine 35mg Tablets, inform your doctor or pharmacist about your medical history and all prescription medicines, over-the-counter products, supplements, and herbal remedies you use.
Particular caution is required if you have:
Parkinson's disease or symptoms such as tremor, muscle stiffness, or slowed movement.
Restless legs syndrome or other movement disorders.
Severe kidney impairment.
Moderate kidney impairment, which may require a lower dose.
Balance problems, unsteady walking, or a history of falls.
Low blood pressure or dizziness, particularly when taking other cardiovascular medicines.
Trimetazidine should not be used in patients with Parkinson's disease, parkinsonian symptoms, tremors, restless legs syndrome, or severe renal impairment.
The medicine can cause or worsen movement disorders, including parkinsonian symptoms. New tremors, muscle stiffness, or walking difficulties require medical assessment and discontinuation of trimetazidine.
No major specific medicine interactions have been consistently established, but caution is appropriate when trimetazidine is used alongside blood pressure-lowering medicines because dizziness or falls may occur.
Always check possible interactions with your doctor or pharmacist before starting treatment.
Pregnancy & Breastfeeding
Pregnancy: Information about trimetazidine use during pregnancy is limited. As a precaution, its use is generally avoided during pregnancy unless a healthcare professional determines that treatment is necessary after assessing the potential benefits and risks.
Breastfeeding: It is not known whether trimetazidine passes into human breast milk. Because a risk to the breastfed infant cannot be excluded, breastfeeding is generally not recommended during treatment.
If you are pregnant, planning a pregnancy, or breastfeeding, consult your doctor or pharmacist before taking trimetazidine.
Side Effects
Like all medicines, Trimetazidine can cause side effects, although not everyone experiences them.
Common side effects may include:
Seek prompt medical attention if you develop new tremors, muscle stiffness, slowed movement, unsteady walking, or restless legs. Serious allergic reactions, including facial swelling or difficulty breathing, also require immediate medical attention.
This is not a complete list of side effects or warnings. Please refer to the product packaging and patient information leaflet supplied with your medicine for complete information and speak with your doctor or pharmacist if you have concerns.
Storage
Store Trimetazidine 35mg Tablets according to the instructions shown on the original product packaging.
Keep the tablets in their original packaging.
Protect from excessive heat and moisture as directed on the label.
Keep out of the sight and reach of children.
Do not use after the expiry date printed on the packaging.